Financials

News Ideas Technicals

VISTN fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Vistin Pharma ASA engages in the manufacture and sale of metformin products. It offers Metformin HCI and Metformin DC. It operates through the following segments: Pharmaceuticals, Energy Trading, and Headquarter and Other. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

VISTN does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company